1. Balato A, Cacciapuoti S, Di Caprio R, et al. Human microbiome: composition and role in inflammatory skin diseases. Arch Immunol Ther Exp 2019; 67: 1-8.
2.
Mazzei R, Leonti M, Spadafora S, et al. A review of the antimicrobial potential of herbal drugs used in popular Italian medicine (1850s–1950s) to treat bacterial skin diseases. J Ethnopharmacol 2020; 250: 112443.
3.
Xue Y, Zhou J, Xu BN, et al. Global burden of bacterial skin diseases: a systematic analysis combined with sociodemographic index, 1990–2019. Front Med 2022; 9: 861115.
4.
Ito Y, Amagai M. Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases. Inflamm Regen 2022; 42: 26.
5.
Yew YW, Kuan AH, George PP, et al. Prevalence and burden of skin diseases among the elderly in Singapore: a 15-year clinical cohort study. J Eur Acad Dermatol Venereol 2022; 36: 1648-59.
6.
Dallo M, Patel K, Hebert AA. Topical antibiotic treatment in dermatology. Antibiotics 2023; 12: 188.
7.
Shu WJ, Yao XL, Chen ZY, et al. Pharmacological study and clinical application of Ra-dix Bupleuri. J Guangxi Acad Sci 2017; 33: 268-73.
8.
Long J, Ji W, Zhang D, et al. Bioactivities and structure – activity relationships of fusidic acid derivatives: a review. Front Pharmacol 2021; 12: 759220.
9.
O’Sullivan JN, Rea MC, Hill C, Ross RP. Protecting the outside: biological tools to manipulate the skin microbiota. FEMS Microbiol Ecol 2020; 96: fiaa085.
10.
Gangwar A, Kumar P, Singh R, Kush P. Recent advances in mupirocin delivery strategies for the treatment of bacterial skin and soft tissue infection. Future Pharmacol 2021; 1: 80-103.
11.
Russo F, Cioppa V, Cartocci A, et al. Exploring the relationship between dermatology life quality index, eczema area and severity index, and sleep numerical rating scale and pruritus numerical rating scale in patients with atopic dermatitis treated with dupilumab. Dermatitis 2023; 34: 440-4.
12.
Tao R, Li R, Wang R. Skin microbiome alterations in seborrheic dermatitis and dandruff: a systematic review. Exp Dermatol 2021; 30: 1546-53.
13.
Singal A, Lipner SR. A review of skin disease in military soldiers: challenges and potential solutions. Ann Med 2023; 55: 2267425.
14.
Narayanan V, Motlekar S, Kadhe G, Bhagat S. Efficacy and safety of nadifloxacin for bacterial skin infections: results from clinical and post-marketing studies. Dermatol Ther (Heidelb) 2014; 4: 233-48.
15.
Bonamonte D, De Marco A, Giuffrida R, et al. Topical antibiotics in the dermatological clinical practice: indications, efficacy, and adverse effects. Dermatol Ther 2020; 33: e13824.
16.
Nochaiwong S, Ruengorn C, Noppakun K, et al. Comparative effectiveness of local application of chlorhexidine gluconate, mupirocin ointment, and normal saline for the prevention of peritoneal dialysis-related infections (COSMO-PD trial): a multicenter randomized, double-blind, controlled protocol. Trials 2019; 20: 754.
17.
Sharma M, Malik G, Gulati D, et al. Formulation and evaluation of fusidic acid based transferosome for burn wound infection. Mater Today Proc 2022; 68: 836-41.
18.
Waqas MK, Sadia H, Khan MI, et al. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches. Des Monomers Polym 2022; 25: 165-74.
19.
Demessant-Flavigny AL, Connétable S, Kerob D, et al. Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: a narrative review. J Eur Acad Dermatol Venereol 2023; 37: 3-17.
20.
Heal C, Gorges H, Van Driel ML, et al. Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo. BMJ Open 2019; 9: e031527.
21.
Neri I, Del Giudice MM, Novelli A, et al. Ideal features of topical antibiotic therapy for the treatment of impetigo: an Italian expert consensus report. Curr Ther Res 2023; 98: 100690.
22.
Bandyopadhyay D. Topical antibacterials in dermatology. Indian J Dermatol 2021; 66: 117-25.
23.
Wiala A, Daschl SM, Stockinger T, et al. Oral fusidic acid for the treatment of mild-to-moderate hidradenitis suppurativa. Int J Dermatol 2024; 63: 1205-11.
24.
Blaskovich MA, Elliott AG, Kavanagh AM, et al. In vitro antimicrobial activity of acne drugs against skin-associated bacteria. Sci Rep 2019; 9: 14658.
25.
Swaney MH, Kalan LR. Living in your skin: microbes, molecules, and mechanisms. Infect Immun 2021; 89: e00695-20.
